YOUR BUSINESS AUTHORITY
Springfield, MO
Generic drug manufacturer Mallinckrodt Pharmaceuticals reached a tentative deal to settle opioid claims.
Through the deal, Mallinckrodt would pay a $1.6 billion settlement and enter its generics business into Chapter 11 bankruptcy.
The settlement comes amid thousands of lawsuits in a federal case that seeks to determine who should be held financially liable for the impact of the opioid crisis.
Read more from The Washington Post.
Missouri State University’s science building, built in 1971 and formerly called Temple Hall, is being reconstructed and updated.